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THE PLACE OF IMMUNOTHERAPY IN TH E MANAGEME T OF EXTENSIVE BURNS
ISOBEL M. RIDING, PH.D. AND SYDNEY COHE ,* F.R.C.S., A.LC.S., Regional Blood Transfusion Cenrre, Edinburgh
and the Department of Plastic Surgery, Royal Hospiral for Sick Children, Edinburgh
Suggestions from earlier workers seemed to indicate that in
burned tissue a specific antigen developed which stimulated
the formation of an antibody a short while after receipt of
the injury. If this hypothesis is correct, then plasma from
a convalescent burn, if given to a recent injury, should
reduce the effect of the trauma. However, positive evidence
in virro was required to prove the existence of a 'burn
antigen' and 'burn antibody'. An investigation was there-
fore instituted in the Regional Blood Transfusion Centre,
Edinburgh, using sera from recent and convalescent cases
of burns treated in the Department of Plastic SU1"gery at
the Royal Hospital for Sick Children, Edinburgh. This
paper records these studies, discusses the results and re-
views the literature on immunotherapy in the management
of the extensive burn.
Immunoelectrophoresis of the 6 sera involved in the
diffusion plate was then carried out and any possible
inc~eases in proteins noted. Photographs of 3 of the sera
tested are shown in Fig. 2. Further immunoelectrophoretic
--'----_._~_.._-------------
METHOD
Diffusion plates were prepared using 15 m!. of 1·5% agar
in barbitone pH 8·6 (u=O·05). Anti-whole human serum
was used to indicate a definite positive reaction. Serum
samples were chosen from 5 patients in different stages of
recovery from extensive burns and these were set to diffuse
against a serum sample from a case of extensive burns only
20-hours old. The results are shown in Fig. 1.
'Presently plastic surgeon, Cape Town.
Fig. 1. Agar diffusion of burn sera. Note expected preci-
pitation arcs between anti-whole human globulin and the 2
adjacent sera (Y.Y. and M.K.). Faint reaction arcs between
serum from recent burn (Dryden) and the 2 adjacent con-
valescent sera (Y.Y. and M.K.).
RESULTS
Agar DifJusion
Besides the expected precipitation arcs between the anti-
whole human serum and the 2 adjacent convalescent burn
sera, faint extra arcs between 2 of the convalescent sera
(M.K. and Y.Y. in Fig. I) and serum from a recent burn
(Dryden, Fig. 1) were present.
lmmunoelectrophoresis
The results from the 6 sera were as follows:
Fig. 2. Comparison of specific immunoelectrophoresis
slides. Top: M.K. Centre: Dryden. Lower: Y.Y. Analy-
sis: Top: increased B-lipoprotein, increased y,M globulin
(19S). Centre: increased B-lipoprotein, increased hapto-
globulin, slight increase y,M globulin and y,A globulin;
possible y,globulin increase. Lower: approximately nor-
mal level B-lipoprotein and y,M globulin.
studies were carried out using a variety of serum samples
but replacing the anti-whole human serum by serum from
a recent burn. This was done in order to concentrate any
antibody in the convalescent sera, thereby increasing the
possibility of producing a positive reaction.
Dryden 20 hours post~burn.
Anti-whole human serum
M.K. 24 Jays post-burn.
e.S. 61 days post-burn.
G.S. 30 days post-burn .
R.W. 44 days post-burn.












• : Eeaction Arcs.
o 0o
596 S.A. TYDSKRIF VIR GENEESKUNDE 9 Julie 1966
CONCLUSIONS
The question of the existence of a 'burn toxin' with its specific
antitoxin has been strongly debated over the last decade.
children under the age of 10 years, all suffering from severe
and extensive burns, were transfused daily for a week com-
mencing 48 hours after injury. Efficacy was assessed on
the mortality rate, duration of survival, level of leucocyte
count and the presence of a positive blood culture. Of the
series not 1 case survived, death being due in each instance
to intercurrent infection most frequently involving the
respiratory tract; there was no difference in the duration
of survival between the test and control series; no definite
pattern existed in so far as the leucocyte levels were con-
cerned; finally there was no difference in the incidence of
positive blood cultures.
Craig concluded that there was a possibility that freez-
ing destroyed any active principle in convalescent serum;
if so, then the practical effects of administering con-
valescent serum were greatly limited because of the diffi-
culty in obtaining fresh serum for each new case of ther-
mal trauma. If freezing did not exert any ill-effect, then it
would appear that there was no benefit or value in the use
of convalescent serum.
In the appraisal of Craig's results and conclusions, the
observations of Maim and Slawikowski,' based on work
done at the Waiter Reed Army Institute of Research,
should be borne in mind. These workers felt that the effects
of convalescent serum could not be measured in terms of
differences in survival rate in the early post-burn period;
should a 'burn antibody' exist, its effects would be re-
lated to morbid rather than lethal factors.
The argument as to whether a 'burn antibody' exists has
been waged in the laboratory as well as in the ward. In
1962 Dobrkovsky et af! reported a series of 30 cases in
which by means of a latex agglutination technique, anti-
bodies against burned skin were demonstrated on the
3rd - 8th post-burn day. Titres gradually fell until by the
6th month no antibodies were found in the circulating
blood. Rosenthal et af.' claimed the presence of immune
bodies in the plasma of burned patients by means of a pre-
cipitation technique. Artussen and Fjellstrom'o showed that
there was reduction in complement towards the end of the
1st week in the severe burn. Although they admit that
there may be many reasons for this, they suggest that the
reduction may be due to fixation following antigen-anti-
body reactions. On our own studies, no specific reactions
were recorded to indicate the presence of a 'burn antibody'
in the cases under investigation. The consistent increase of
B-lipoprotein was not considered immunologically signi-
ficant.
The National Research Council of America has issued
a directive in which it states that no statistically acceptable
evidence for the support of a burn toxin-antitoxin exists.
The clinical evidence, at .least that which is produced by
workers in Western countries, seems to concur with this
point of view. Bacteriologically, the findings are equivocal.
It would appear that the view expressed by Virginia
Blocker,ll namely that the possible benefits from 'immuno-
transfusions' are related to antibodies against micro-
organisms rather than to true 'burn antigens', may be the
answer to the problem. From the results of our own inves-








Patient Time afler B-Iipn-
injury prolein
Dryden 20 hours ?+
M.K. 24 days ?+
C.S. 61 days + -L +
G.S. 30 days + +
R.W. 44 days +
Y.Y. 47 days +
As can be seen, the experiments were not really conclu-
sive and no specific reactions were recorded. Studies on
adsorption of antigen-antibody were carried out but with
equally little success.
DISCUSSIO
In 1876 Avdakoff' found that the blood of burned animals
was toxic if injected into healthy animals of the same
species. In 1952 Simonarf repeated these experiments and
indicated that the enzymatic hydrolysis of the serum pro-
teins resulted in a toxic substance similar in nature to the
euglobulin fraction extracted from burn exudate.
With modern therapy few patients suffering from severe
and extensive burns die in the initial phase of resuscitation.
Death is more likely to occur later during the first and
second weeks following receipt of the injury. Besides the
obvious effects of infection, one of the factors considered
to be responsible f(;)r this mortality is the so-called 'burn
toxaemia'. The condition is supposed to follow the absorp-
tion of toxic products of autolysis of the necrotic tissue.
It may be possible that some of these toxins possess anti-
genic properties stimulating specific antibody formation.
Since it is most likely that maximum antibody titre would
occur in convalescence, the transfusion of a quantity of
convalescent burn serum into a patient suffering from a
severe burn, would have the effect of reducing the general
effects of the injury.
Work carried out in the Eastern European countries and
which initially served to focus attention on immunotherapy
in the treatment of burns, was reported in optimistic terms.
In 1956 Feodorov and Skurkovich3 described the beneficial
effects following the injection of convalescent serum.
Patients so treated became more active, their temperature
and leucocytosis fell and wound healing was more rapid.
In 1964 Blocker et al.4 described an investigation carried
out in their laboratories wherein burn serum was adminis-
tered to a number of dogs with standardized scalds. The
convalescent serum had been obtained from dogs which
had sustained 20°;; scalds within the previous 3 months.
The results, assessed by changes in the pulse, temperature,
blood pressure, cardiac output and the electroencephalo-
gram, were of limited interest. They failed to show that
convalescent burn serum was of any value or benefit. An
interesting incidental finding was a fall in the cardiac out-
put and blood pressure immediately after a severe burn
despite correction of hypovolaemia.
Blocker considered this to be the result of a 'toxic
myocarditis'; it was however unaffected by the adminis-
tration of convalescent burn serum. It is of interest to re-
call that Fozzard' had earlier drawn attention to the value
of digitalis in the management of the severe burn.
In a recent paper" Craig published the results of a clini-
cal trial of frozen convalescent serum obtained from
extensively burned patients 3 - 6 months after injury. Ten
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Although clinical evidence produced by workers in Eastern
European countries originally seemed to indicate that the use
of convalescent burn serum in the management of the recent
extensive burn was associated with a reduction in the effect of
the injury, further enquiries into the problem by other workers
has not confirmed this. At present it seems that whereas non-
specific antibodies to microorganisms may well occur in the
circulation of the patient convalescing from an extensive burn,
no true 'burn antibody' has been demonstrated. The routine
use of convalescent burn serum is therefore of doubtful value.
We wish to thank Dr. R. A. Cumming, Director of the
Regional Blood Transfusion Centre for his cooperation and
advice. We are also grateful to Mr. A. B. Wallace, CB.E.,
Head of the Department of Plastic Surgery at the Royal Hos-
pital for Sick Children, under whose care the patients were
admitted, for permission to publish this report.
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POST-GASTRECTOMY STEATORRHOEA DUE TO INTESTINAL LACTASE DEFICIENCY
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Assistant, AND 1. N. MARKS, B.sc., M.B., CH.B., F.R.C.P. (EDIN.), Consultant GasTroenterologisT .. From The Gaslro-
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and Groote Schuur Hospital, Observatory, CP
Steatorrhoea following partial gastrectomy may be associ-
ated with a disturbing loss of weight, osteoporosis, hypo-
calcaemia and anaemia due to the continued loss of fat,
proteins, minerals and vitamins. Many factors have been
incriminated in the production of the steatorrhoea, but a
definitive aetiological factor is not always demonstrable.
Treatment ranges from a conservative medical approach
with constipating agents, a trial of pancreatic replacement
therapy and antibiotics, to surgical measures such as en-
larging the gastric reservoir or re-establishing gastro-duo-
denal continuity.
The purpose of this paper is to report an unusual type
of post-gastrectomy steatorrhoea which is readily amenable
to simple dietary measures. The steatorrhoea was asso-
ciated with an intolerance to dairy products and virtually
disappeared on eliminating the latter from the diet.
CASE REPORT
The patient, a 49-year-old housewife, was admitted with a his-
10ry of diarrhoea, loss of weight, flalUlence and malaise follow-
ing a vagotomy and partial gastrectomy carried out for intrac-
table duodenal ulceration 9 months previously. The diarrhoea
developed in the immediate postoperative period and was
characterized by Ihe passage of up to 10 loose, frolhy, yel-
lowish stools per day. The bowel actions tended to occur 20 -
30 minules after a meal and were frequently accompanied by
episodes of vomiting, headaches and extreme lethargy. Weight
loss was a feature, the patienl's weight having fallen from 167
to 120 lb. She was referred to the Gastro-Intestinal Service
after initial treatment with anticholinergics and antacids had
failed to influence her symptoms. Further queslioning showed
Ihat the diarrhoea was of a particularly explosive nature after
eating cheese, butter or milk with her meals. She had, in fact,
omitled dairy products from her diet inlermittently with
marked clinical improvement. There was no hislory of sensi-
tivity to dairy products before her operation and there was
no childhood history of diarrhoea. Clinical examination was
non-contributory apart from slight weight loss and mild hyper-
tension of the order of 160 mm.Hg systolic and 100 mm.Hg
diastolic. The haemoglobin was 13·5 G/lOO ml., PCV 44°~,
ESR 7 mm./hr. (Westergren) and the WBC 7,200/cu.mm.
Urinalysis was normal.
Laboratory investigations showed that the serum proteins.
liver-function tests, blood urea, serum bilirubin and alkaline
phosphates were normal. An augmented histamine test revealed
a hislamine-fast achlorhydria. Stool examinations were re-
peatedly negative for pathogens, and a culIure of bile obtained
at jejunal biopsy showed nasopharyngeal bacleria only. Urinary
Co"B" excretion was normal at 20·1 G I 100 ml. of the ad-
minislered dose after 24 hours and the serum B" and folate
levels were within normal range. Peroral jejunal biopsy car-
ried out during a phase of marked diarrhoea yielded morpho-
logically normal jejunal mucosa. Disaccharidase determinations
were carried out on a 50 mg. specimen of jejunal mucosa after
the method of Auricchio.' The disaccharidase activity per G
of prolein was lactase 2 units, sucrase 151 units and malIase
598 units (Table I).
TABLE l. DISACCHARIDASE ACTIVITY IN SMALL BOWEL MUCOSA IN
CONTROL SUBJECTS A '0 A PATIENT WITH POST-GASTRECTOMY STEATOR-
RHOEA
LacTase Sucrase MalTase
(unitslG (I/niTsIG (I/niTS IG
AlIlhor prOTein) prOTein) prOTein)
range range range
Sonntag eT aJ! 6-258 24-325 70-1,120
Haemmerli eT aJ" 7-285* 49-325 217-1,120
Sheehy & Anderson' 4-149 21-247 52-816
Barbezat eT aJ.5 64-108 150-389 220-1,325
Present case 2 151 598
*Haemmerli eT aJ" consider 7-20 units as abnormally low activity
in subjects free of gastro-intestinal symptoms.
A glucose-tolerance test was carried out following the oral
administralion of 50 G of glucose and the lest wa3 repeated.
on alternate days, using 50 G of sucrose, malIose and lac-
tose respectively. The tolerance test following malIose showed
the typical post-gastrectomy alimentary hyperglycaemia. The
latter was also apparent, but to a lesser degree, after glucose
and sucrose. These curves contrasted sharply with the flat
tolerance test following lactose (Fig. I).
Fat absorption was measured by means of labelled triolein
and biochemical methods. The stool radioactivity and faecal
fat conlenl were determined on each of the 2 successive 5-day
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